Hastening Death by Voluntarily Stopping Eating and Drinking

Activity Evaluation

“Hastening Death by Voluntarily Stopping Eating and Drinking:

Clinical, Legal, Ethical, Religious, and Family Perspectives”

“October 14-15, 2016”

Please complete this evaluation form and return it to the Foyer Registration Desk prior to your departure. The first section lists each presentation. Please evaluate the presentations that you attend. The second section concerns the overall course. Please complete it before turning in the evaluation form. Circle your responses and write in your comments. The course planning committee appreciates your reactions and suggestions to develop and improve future conferences.

Was the Content Relevant / Rate the Quality of
to My Work and / or Practice? / Each Presentation?

Not at All Very Much

Poor Excellent

Saturday, October 15, 2016
Legal and Ethical Issues
Chair: Patricia Kuszler, MD JD, Professor of Law, U of Washington School of Law
Norman L. Cantor, JD, Professor of Law & Justice (emeritus), Rutgers University
Annette Clark, MD, JD, Professor and Dean, Seattle University School of Law
Margaret Battin, PhD, Professor of Philosophy, University of Utah
Carla Calogero, JD, Reed LongyearMalnati & Ahrens, PLLC, Seattle / 1 / 2 / 3 / 4 / 5 / 6 / 1 / 2 / 3 / 4 / 5 / 6
Dementia, Depression and Capacity Determination
Chair: Sarah Shannon, RN, PhD, Biobehavioral Nursing & Health Systems, Oregon Health Sciences University
Linda Ganzini, MD, MPH, Geriatric Psychiatry, Oregon Health Sciences University / 1 / 2 / 3 / 4 / 5 / 6 / 1 / 2 / 3 / 4 / 5 / 6
VSED by Advance Directive (dementia, etc.)
Chair: Lisa Brodoff, JD, Director, Ronald A. Peterson Law Clinic, Seattle University School of Law
Norman L. Cantor, JD, Professor of Law & Justice (emeritus), Rutgers University School of Law
Stanley Terman, MD, PhD, Medical Director, Caring Advocates, Carlsbad CA
Paul Menzel, PhD, Professor of Philosophy (emeritus), Pacific Lutheran University / 1 / 2 / 3 / 4 / 5 / 6 / 1 / 2 / 3 / 4 / 5 / 6
Institutional Considerations (hospice, palliative care, nursing homes)
Chair: David Gruenewald, MD, Medical Director, Palliative Care & Hospice, VA Puget Sound
Hope Wechkin, MD, Evergreen Health Hospice, Kirkland
Patricia Hunter, Washington State Long Term Care Ombudman
Amy Freeman, JD, Attorney, Washington State Long Term Care Ombudsman Program
TresaMariotto, CDMHT, Social Services Supervisor, Skilled Nursing Homes, State of Washington; former Executive Director, Woodway Senior Living, Bellingham / 1 / 2 / 3 / 4 / 5 / 6 / 1 / 2 / 3 / 4 / 5 / 6
Capstone Panel: brief observations, in light of the conference, toward a comprehensive comparative assessment of VSED
Chair: Sara Goering, PhD, Associate Professor of Philosophy, University of Washington
Thaddeus Pope, JD, PhD, Mitchell Hamline School of Law
Timothy Quill, MD, University of Rochester School of Medicine
Sarah Shannon, RN, PhD, Biobehavioral Nursing & Health Systems, Oregon Health Sciences University
Paula Span, NY Times, New Old Age blog, author
Audience Comments & Questions / 1 / 2 / 3 / 4 / 5 / 6 / 1 / 2 / 3 / 4 / 5 / 6

Your comments regarding lectures:

______

Activity Objectives:

At the conclusion of this activity, participants should be able to:

Describe at least three steps a clinician should take in response to a patient’s request for VSED
Describe at least one risk, one benefit, and one burden of VSED for patients choosing VSED at the end of life
Discuss at least one intervention clinicians can perform to minimize symptoms for people actively engaging in VSED
Discuss at least one ethical concern about VSED as an option near the end of life
Discuss at least one potential barrier to VSED for residents in an institutional setting
Discuss the current legal status of VSED in the United States
Compare and contrast VSED with other “treatments of last resort” for people facing end of life, including palliative sedation and physician assisted dying

Please rate your agreement with the following statements based on your experience with this conference. / No / Not Sure / Somewhat / Yes
Theactivity objectives were met / 1 / 2 / 3 / 4
There was adequate opportunity to ask
questions during the activity / 1 / 2 / 3 / 4
The content was free of commercial bias / 1 / 2 / 3 / 4
The information presented in this educational activity enhanced my current knowledge / 1 / 2 / 3 / 4
The information presented in this educational activity provided new ideas or information I expect to use / 1 / 2 / 3 / 4
The information presented in this educational activity addressed competencies identified by my specialty / 1 / 2 / 3 / 4
Do you intend to make changes or apply what you’ve learned to your practice as a result of attending this activity? / 1 / 2 / 3 / 4

List one thing you intend to change in your practice as a result of the information you received from this activity. ______

How do you think these changes will affect your patient outcomes?

______

Please provide general comments regarding this activity and suggest how it might be improved

______

Suggestions for future topics: ______

THANK YOU